<DOC>
	<DOC>NCT00002065</DOC>
	<brief_summary>To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.</brief_summary>
	<brief_title>Depot Disulfiram for AIDS and ARC</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Disulfiram</mesh_term>
	<criteria>Inclusion Criteria Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria. Also patient must be: Able to understand the study. Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms. Ambulatory and able to maintain an independent life outside the hospital. Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. History of alcohol abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Delayed-Action Preparations</keyword>
	<keyword>Disulfiram</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>